Advertisement

Postpartum intrauterine devices: clinical and programmatic review

      The immediate postpartum period is a critical moment for contraceptive access and an opportunity to initiate long-acting reversible contraception, which includes the insertion of an intrauterine device. The use of the intrauterine device in the postpartum period is a safe practice with few contraindications and many benefits. Although an intrauterine device placed during the postpartum period is more likely to expel compared with one placed at the postpartum visit, women who initiate intrauterine devices at the time of delivery are also more likely to continue to use an intrauterine device compared with women who plan to follow up for an interval intrauterine device insertion. This review will focus on the most recent clinical and programmatic updates on postpartum intrauterine device practice. We discuss postpartum intrauterine device expulsion and continuation, eligibility criteria and contraindications, safety in regards to breastfeeding, and barriers to access. Our aim is to summarize evidence related to postpartum intrauterine devices and encourage those involved in the healthcare system to remove barriers to this worthwhile practice.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rossier C.
        • Bradley S.E.
        • Ross J.
        • Winfrey W.
        Reassessing unmet need for family planning in the postpartum period.
        Stud Fam Plann. 2015; 46: 355-367
        • DeFranco E.A.
        • Ehrlich S.
        • Muglia L.J.
        Influence of interpregnancy interval on birth timing.
        BJOG. 2014; 121: 1633-1640
        • Conde-Agudelo A.
        • Rosas-Bermudez A.
        • Kafury-Goeta A.C.
        Birth spacing and risk of adverse perinatal outcomes: a meta-analysis.
        JAMA. 2006; 295: 1809-1823
        • Conde-Agudelo A.
        • Rosas-Bermudez A.
        • Kafury-Goeta A.C.
        Effects of birth spacing on maternal health: a systematic review.
        Am J Obstet Gynecol. 2007; 196: 297-308
        • Shachar B.Z.
        • Lyell D.J.
        Interpregnancy interval and obstetrical complications.
        Obstet Gynecol Surv. 2012; 67: 584-596
        • ACOG Committee Opinion No
        736: optimizing postpartum care.
        Obstet Gynecol. 2018; 131: e140-e150
      1. Report of a WHO Technical Consultation on Birth Spacing. WHO, Geneva, Switzerland2005 (Available at:) (Accessed July 1, 2018)
        • McDonald E.A.
        • Brown S.J.
        Does method of birth make a difference to when women resume sex after childbirth?.
        BJOG. 2013; 120: 823-830
        • Committee on Practice Bulletins-Gynecology L-ARCWG
        Practice Bulletin No. 186: long-acting reversible contraception: implants and intrauterine devices.
        Obstet Gynecol. 2017; 130: e251-e269
        • Moniz M.H.
        • Chang T.
        • Heisler M.
        • et al.
        Inpatient postpartum long-acting reversible contraception and sterilization in the United States, 2008-2013.
        Obstet Gynecol. 2017; 129: 1078-1085
      2. Comparative multicentre trial of three IUDs inserted immediately following delivery of the placenta.
        Contraception. 1980; 22: 9-18
        • Chi I.C.
        • Wilkens L.
        • Rogers S.
        Expulsions in immediate postpartum insertions of Lippes loop D and Copper T IUDs and their counterpart Delta devices: an epidemiological analysis.
        Contraception. 1985; 32: 119-134
        • Cox M.L.
        The Dalkon Shield saga.
        J Fam Plann Reprod Health Care. 2003; 29: 8
        • Darney P.D.
        Time to pardon the IUD?.
        N Engl J Med. 2001; 345: 608-610
        • Lopez L.M.
        • Bernholc A.
        • Hubacher D.
        • Stuart G.
        • Van Vliet H.A.
        Immediate postpartum insertion of intrauterine device for contraception.
        Cochrane Database Syst Rev. 2015; 6: CD003036
        • Blumenthal P.D.
        • Eber M.
        • Vajpayee J.
        Dedicated inserter facilitates immediate postpartum IUD insertion.
        Glob Health Sci Pract. 2013; 1: 428-429
        • Singh S.
        • Das V.
        • Agarwal A.
        • et al.
        A dedicated postpartum intrauterine device inserter: pilot experience and proof of concept.
        Glob Health Sci Pract. 2016; 4: 132-140
        • Xu J.X.
        • Rivera R.
        • Dunson T.R.
        • et al.
        A comparative study of two techniques used in immediate postplacental insertion (IPPI) of the Copper T-380A IUD in Shanghai, People’s Republic of China.
        Contraception. 1996; 54: 33-38
        • Blumenthal P.D.
        • Lerma K.
        • Bhamrah R.
        • Singh S.
        • Dedicated PIWG
        Comparative safety and efficacy of a dedicated postpartum IUD inserter versus forceps for immediate postpartum IUD insertion: a randomized trial.
        Contraception. 2018; ([Epub ahead of print])https://doi.org/10.1016/j.contraception.2018.04.019
        • Goldthwaite L.M.
        • Sheeder J.
        • Hyer J.
        • Tocce K.
        • Teal S.B.
        Postplacental intrauterine device expulsion by 12 weeks: a prospective cohort study.
        Am J Obstet Gynecol. 2017; 217: 674.e1-674.e8
        • Zhou S.W.
        • Chi I.C.
        Immediate postpartum IUD insertions in a Chinese hospital: a two year follow-up.
        Int J Gynaecol Obstet. 1991; 35: 157-164
        • Letti Muller A.L.
        • Lopes Ramos J.G.
        • Martins-Costa S.H.
        • et al.
        Transvaginal ultrasonographic assessment of the expulsion rate of intrauterine devices inserted in the immediate postpartum period: a pilot study.
        Contraception. 2005; 72: 192-195
        • Whitaker A.K.
        • Chen B.A.
        Society of Family Planning guidelines: postplacental insertion of intrauterine devices.
        Contraception. 2018; 97: 2-13
        • Levi E.E.
        • Stuart G.S.
        • Zerden M.L.
        • Garrett J.M.
        • Bryant A.G.
        Intrauterine device placement during cesarean delivery and continued use 6 months postpartum: a randomized controlled trial.
        Obstet Gynecol. 2015; 126: 5-11
        • Whitaker A.K.
        • Endres L.K.
        • Mistretta S.Q.
        • Gilliam M.L.
        Postplacental insertion of the levonorgestrel intrauterine device after cesarean delivery vs delayed insertion: a randomized controlled trial.
        Contraception. 2014; 89: 534-539
        • Dahlke J.D.
        • Terpstra E.R.
        • Ramseyer A.M.
        • Busch J.M.
        • Rieg T.
        • Magann E.F.
        Postpartum insertion of levonorgestrel--intrauterine system at three time periods: a prospective randomized pilot study.
        Contraception. 2011; 84: 244-248
        • Chen B.A.
        • Reeves M.F.
        • Hayes J.L.
        • Hohmann H.L.
        • Perriera L.K.
        • Creinin M.D.
        Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial.
        Obstet Gynecol. 2010; 116: 1079-1087
        • Bednarek P.H.
        • Creinin M.D.
        • Reeves M.F.
        • et al.
        Immediate versus delayed IUD insertion after uterine aspiration.
        N Engl J Med. 2011; 364: 2208-2217
        • Fox M.C.
        • Oat-Judge J.
        • Severson K.
        • et al.
        Immediate placement of intrauterine devices after first and second trimester pregnancy termination.
        Contraception. 2011; 83: 34-40
        • Cremer M.
        • Bullard K.A.
        • Mosley R.M.
        • et al.
        Immediate vs delayed post-abortal Copper T 380A IUD insertion in cases over 12 weeks of gestation.
        Contraception. 2011; 83: 522-527
        • Hohmann H.L.
        • Reeves M.F.
        • Chen B.A.
        • Perriera L.K.
        • Hayes J.L.
        • Creinin M.D.
        Immediate versus delayed insertion of the levonorgestrel-releasing intrauterine device following dilation and evacuation: a randomized controlled trial.
        Contraception. 2012; 85: 240-245
        • Lester F.
        • Kakaire O.
        • Byamugisha J.
        • et al.
        Intracesarean insertion of the Copper T380A versus 6 weeks postcesarean: a randomized clinical trial.
        Contraception. 2015; 91: 198-203
        • Sucak A.
        • Ozcan S.
        • Celen S.
        • Caglar T.
        • Goksu G.
        • Danisman N.
        Immediate postplacental insertion of a Copper intrauterine device: a pilot study to evaluate expulsion rate by mode of delivery.
        BMC Pregnancy Childbirth. 2015; 15: 202
        • Celen S.
        • Sucak A.
        • Yildiz Y.
        • Danisman N.
        Immediate postplacental insertion of an intrauterine contraceptive device during cesarean section.
        Contraception. 2011; 84: 240-243
        • Jatlaoui T.C.
        • Marcus M.
        • Jamieson D.J.
        • Goedken P.
        • Cwiak C.
        Postplacental intrauterine device insertion at a teaching hospital.
        Contraception. 2014; 89: 528-533
        • Blumenthal P.D.
        • Chakraborty N.M.
        • Prager S.
        • Gupta P.
        • Lerma K.
        • Vwalika B.
        Programmatic experience of post-partum IUD use in Zambia: an observational study on continuation and satisfaction.
        Eur J Contracept Reprod Health Care. 2016; 21: 356-360
        • Eggebroten J.L.
        • Sanders J.N.
        • Turok D.K.
        Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
        Am J Obstet Gynecol. 2017; 217: 51.e1-51.e7
        • Curtis K.M.
        • Tepper N.K.
        • Jatlaoui T.C.
        • et al.
        US medical eligibility criteria for contraceptive use, 2016.
        MMWR Recomm Rep. 2016; 65: 1-103
        • American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice. Committee Opinion No
        670: immediate postpartum long-acting reversible contraception.
        Obstet Gynecol. 2016; 128: e32-e37
        • Committee on Practice Bulletins–Obstetrics
        Practice Bulletin No. 183: Postpartum hemorrhage.
        Obstet Gynecol. 2017; 130: e168-e186
        • World Health Organization
        Medical eligibility criteria for contraceptive use.
        5th ed. WHO Press, Geneva, Switzerland2015
        • Sriraman N.K.
        The nuts and bolts of breastfeeding: anatomy and physiology of lactation.
        Curr Probl Pediatr Adolesc Health Care. 2017; 47: 305-310
        • Phillips S.J.
        • Tepper N.K.
        • Kapp N.
        • Nanda K.
        • Temmerman M.
        • Curtis K.M.
        Progestogen-only contraceptive use among breastfeeding women: a systematic review.
        Contraception. 2016; 94: 226-252
        • Seeber B.
        • Ziehr S.C.
        • Gschliebetaer A.
        • et al.
        Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system.
        Contraception. 2012; 86: 345-349
        • Bennink H.J.
        The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant.
        Eur J Contracept Reprod Health Care. 2000; 5: 12-20
        • Orme M.L.
        • Back D.J.
        • Breckenridge A.M.
        Clinical pharmacokinetics of oral contraceptive steroids.
        Clin Pharmacokinet. 1983; 8: 95-136
        • Chen B.A.
        • Reeves M.F.
        • Creinin M.D.
        • Schwarz E.B.
        Postplacental or delayed levonorgestrel intrauterine device insertion and breast-feeding duration.
        Contraception. 2011; 84: 499-504
        • Turok D.K.
        • Leeman L.
        • Sanders J.N.
        • et al.
        Immediate postpartum levonorgestrel intrauterine device insertion and breast-feeding outcomes: a noninferiority randomized controlled trial.
        Am J Obstet Gynecol. 2017; 217: 665.e1-665.e8
        • Moniz M.H.
        • Spector-Bagdady K.
        • Heisler M.
        • Harris L.H.
        Inpatient postpartum long-acting reversible contraception: care that promotes reproductive justice.
        Obstet Gynecol. 2017; 130: 783-787
        • Zerden M.L.
        • Tang J.H.
        • Stuart G.S.
        • Norton D.R.
        • Verbiest S.B.
        • Brody S.
        Barriers to receiving long-acting reversible contraception in the postpartum period.
        Womens Health Issues. 2015; 25: 616-621
        • Washington C.I.
        • Jamshidi R.
        • Thung S.F.
        • Nayeri U.A.
        • Caughey A.B.
        • Werner E.F.
        Timing of postpartum intrauterine device placement: a cost-effectiveness analysis.
        Fertil Steril. 2015; 103: 131-137
        • Rodriguez M.I.
        • Caughey A.B.
        • Edelman A.
        • Darney P.D.
        • Foster D.G.
        Cost-benefit analysis of state- and hospital-funded postpartum intrauterine contraception at a university hospital for recent immigrants to the United States.
        Contraception. 2010; 81: 304-308
      3. Wachino V. State Medicaid payment approaches to improve access to long-acting reversible contraception. CMCS Informational Bulletin: Department of Health and Human Services Centers for Medicare and Medicaid Services; 2016.

        • Higgins T.M.
        • Dougherty A.K.
        • Badger G.J.
        • Heil S.H.
        Comparing long-acting reversible contraception insertion rates in women with Medicaid vs private insurance in a clinic with a two-visit protocol.
        Contraception. 2018; 97: 76-78
        • Biggs M.A.
        • Harper C.C.
        • Malvin J.
        • Brindis C.D.
        Factors influencing the provision of long-acting reversible contraception in California.
        Obstet Gynecol. 2014; 123: 593-602
        • Hofler L.G.
        • Cordes S.
        • Cwiak C.A.
        • Goedken P.
        • Jamieson D.J.
        • Kottke M.
        Implementing immediate postpartum long-acting reversible contraception programs.
        Obstet Gynecol. 2017; 129: 3-9